title: [Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma].
authors.forename: J
authors.initials: J
authors.lastname: García Laraña
authors.forename: J
authors.initials: J
authors.lastname: Díaz Mediavilla
authors.forename: R
authors.initials: R
authors.lastname: Martínez
authors.forename: J J
authors.initials: JJ
authors.lastname: Lahuerta
authors.forename: A
authors.initials: A
authors.lastname: Alegre
authors.forename: J
authors.initials: J
authors.lastname: Odriozola
authors.forename: A
authors.initials: A
authors.lastname: Sureda
authors.forename: J
authors.initials: J
authors.lastname: San Miguel
authors.forename: J
authors.initials: J
authors.lastname: De la Rubia
authors.forename: A
authors.initials: A
authors.lastname: Escudero
authors.forename: E
authors.initials: E
authors.lastname: Conde
authors.forename: J
authors.initials: J
authors.lastname: Bladé
authors.forename: R
authors.initials: R
authors.lastname: Cabrera
authors.forename: J
authors.initials: J
authors.lastname: Gastearena
authors.forename: J
authors.initials: J
authors.lastname: Besalduch
authors.forename: M J
authors.initials: MJ
authors.lastname: Vidal
authors.forename: F
authors.initials: F
authors.lastname: Hernández
authors.forename: J
authors.initials: J
authors.lastname: Rifon
authors.forename: A
authors.initials: A
authors.lastname: Leon
authors.forename: R
authors.initials: R
authors.lastname: Mataix
authors.forename: R
authors.initials: R
authors.lastname: Parody
authors.forename: J M
authors.initials: JM
authors.lastname: Moraleda
authors.forename: C
authors.initials: C
authors.lastname: Solano
authors.forename: J M
authors.initials: JM
authors.lastname: de Pablos
authors.forename: J J
authors.initials: JJ
authors.lastname: Sánchez
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D012008:Recurrence; D012042:Registries / Q000706:statistics & numerical data*; D013030:Spain / Q000453:epidemiology
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha